Primary Aldosteronism: Superselective Embolization vs. Laparoscopic Endocrine Curative Therapy

Inclusion Criteria: * Age 18-60 * Diagnosed with primary aldosteronism according to the 2016 Clinical guidelines of the International Endocrine Society * Primary aldosteronism diagnosed according to international guidelines Unilateral disease by AVS or PET-CT criteria * Patients and their family members signed informed consent and agreed to participate in the study Exclusion Criteria: * A history of severe hypersensitivity to contrast media * Severe liver disease complications, such as thrombocytopenia, esophageal varices rupture bleeding, etc * Renal insufficiency (serum creatinine \> 176mmol/L or estimated glomerular filtration rate \< min.1.73m2) * Combined with other secondary hypertension, such as pheochromocytoma, hypercortisolism, renal vascular hypertension (such as renal artery stenosis), renin secretory tumor, renal parenchymatous hypertension, drug-induced hypertension (such as long-term use of glucocorticoids, contraceptives, estrogen, herbal medicines containing glycyrrhizin), pregnancy hypertension and other secondary hypertension * Combined with genetic diseases: such as false aldosteronism (Liddle syndrome), Bartter syndrome, familial hypokalemia and hypomagnesia (Gitelman syndrome) * Stroke, myocardial infarction and stent implantation occurred in the past 3 months * Serious other diseases, such as heart dysfunction (grade IV), acute infections, autoimmune diseases, various malignant tumors, etc * Participated in other clinical trials within the past 3 months * Pregnant, breastfeeding, or planning a pregnancy * Identify patients with alcohol allergy